Search results

165 results for template

Sorted by Relevance . Sort by Date

  1. Saving sight the NICE way

    Anticipated patient numbers were calculated from PCT data using the NICE template - Costs per patient and infrastructure costs were...

  2. Endorsement

    Formally endorses resources produced by external organisations that support the implementation of NICE guidance and the use of quality standards.

  3. Biosimilar medicines (KTT15)

    The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  4. Process guide for adoption support resources for health technologies (PMG23)

    Process guide for adoption support resources for health technologies

  5. HEART UK FH Toolkit

    The intention is to continue to update the toolkit with new documents, templates and resources as they become available. The objective...

  6. Medicines optimisation: key therapeutic topics – Integrated process statement (PMG13)

    Medicines optimisation: key therapeutic topics – Integrated process statement

  7. Key therapeutic topics – Medicines management options for local implementation: Interim process statement (PMG7)

    Key therapeutic topics – Medicines management options for local implementation: Interim process statement

  8. Tuberculosis (NG33)

    This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults. It aims to improve ways of finding people who have TB in the community and recommends that everyone under 65 with latent TB should be treated. It describes how TB services should be organised, including the role of the TB control board.

  9. Medicines optimisation in chronic pain (KTT21)

    This document summarises the evidence base on medicines optimisation in chronic pain . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  10. Mental health problems in people with learning disabilities: prevention, assessment and management (NG54)

    This guideline covers preventing, assessing and managing mental health problems in people with learning disabilities in all settings (including health, social care, education, and forensic and criminal justice). It aims to improve assessment and support for mental health conditions, and help people with learning disabilities and their families and carers to be involved in their care.

  11. Evidence summaries: new medicines – Integrated process statement (PMG11)

    Evidence summaries: new medicines – Integrated process statement

  12. Epilepsy

    Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

  13. Evidence summaries: unlicensed and off-label medicines – Interim process statement (PMG2)

    Evidence summaries: unlicensed and off-label medicines – Interim process statement

  14. Evidence summaries: unlicensed and off-label medicines – Integrated process statement (PMG14)

    Evidence summaries: unlicensed and off-label medicines – Integrated process statement

  15. The NICE public health guidance development process (third edition) (PMG5)

    The NICE public health guidance development process (third edition)

  16. Methods for the development of NICE public health guidance (third edition) (PMG4)

    Methods for the development of NICE public health guidance (third edition)

  17. Fellows

    Fellows are experience health and social care leaders who are our ambassadors at regional and national levels

  18. Fever in under 5s

    Everything NICE has said on assessing and initiating management of fever with no obvious cause in children under 5 in an interactive flowchart

  19. Developing NICE guidelines: the manual (PMG20)

    Developing NICE guidelines: the manual

  20. Medical technologies evaluation programme process guide (PMG34)

    Medical technologies evaluation programme process guide

  21. Privacy notice

    How we collect and use your personal information, and your rights under data protection legislation